Single-collision scattering of keV-energy Kr ions off a polycrystalline Cu surface

In the keV-energy regime, the scattering of krypton ions off a copper sample has been studied. In addition to the broad energy spectrum arising from multiple-collision scattering, the energy distributions of the backscattered ions exhibit prominent peaks at energies where single-collision (SC) scattering peaks are expected. Such SC peaks were shown to be absent in Sn – Mo/Ru scattering, systems of similar mass ratio and thus similar kinetics. The present Kr on Cu results allow for a comparison to a simulation package as SRIM. An important difference found between the present experiment and the predictions of SRIM is that the SC contribution is observed to decrease with scattering angle, whereas SRIM predicts this contribution to be constant. The intensity of the experimental SC peaks, though much weaker than in the SRIM simulations, may be used as markers to improve SRIM in its description of low-energy heavy particle scattering off surfaces

Mean field effects in a trapped classical gas

In this article, we investigate mean field effects for a bosonic gas harmonically trapped above the transition temperature in the collisionless regime. We point out that those effects can play also a role in low dimensional system. Our treatment relies on the Boltzmann equation with the inclusion of the mean field term. The equilibrium state is first discussed. The dispersion relation for collective oscillations (monopole, quadrupole, dipole modes) is then derived. In particular, our treatment gives the frequency of the monopole mode in an isotropic and harmonic trap in the presence of mean field in all dimensions.Comment: 4 pages, no figure submitted to Phys. Rev.

Condensation and interaction range in harmonic boson traps: a variational approach

For a gas of N bosons interacting through a two-body Morse potential a variational bound of the free energy of a confined system is obtained. The calculation method is based on the Feynman-Kac functional projected on the symmetric representation. Within the harmonic approximation a variational estimate of the effect of the interaction range on the existence of many-particle bound states, and on the N-T phase diagram is obtained.Comment: 14 pages+4 figures, submitted to phys.rev.

Collisionless dynamics of dilute Bose gases: Role of quantum and thermal fluctuations

We study the low-energy collective oscillations of a dilute Bose gas at finite temperature in the collisionless regime. By using a time-dependent mean-field scheme we derive for the dynamics of the condensate and noncondensate components a set of coupled equations, which we solve perturbatively to second order in the interaction coupling constant. This approach is equivalent to the finite-temperature extension of the Beliaev approximation and includes corrections to the Gross-Pitaevskii theory due both to quantum and thermal fluctuations. For a homogeneous system we explicitly calculate the temperature dependence of the velocity of propagation and damping rate of zero sound. In the case of harmonically trapped systems in the thermodynamic limit, we calculate, as a function of temperature, the frequency shift of the low-energy compressional and surface modes.Comment: 26 pages, RevTex, 8 ps figure

Conserving Gapless Mean-Field Theory for Weakly Interacting Bose Gases

This paper presents a conserving gapless mean-field theory for weakly interacting Bose gases. We first construct a mean-field Luttinger-Ward thermodynamic functional in terms of the condensate wave function $\Psi$ and the Nambu Green's function $\hat{G}$ for the quasiparticle field. Imposing its stationarity respect to $\Psi$ and $\hat{G}$ yields a set of equations to determine the equilibrium for general non-uniform systems. They have a plausible property of satisfying the Hugenholtz-Pines theorem to provide a gapless excitation spectrum. Also, the corresponding dynamical equations of motion obey various conservation laws. Thus, the present mean-field theory shares two important properties with the exact theory: ``conserving'' and ``gapless.'' The theory is then applied to a homogeneous weakly interacting Bose gas with s-wave scattering length $a$ and particle mass $m$ to clarify its basic thermodynamic properties under two complementary conditions of constant density $n$ and constant pressure $p$. The superfluid transition is predicted to be first-order because of the non-analytic nature of the order-parameter expansion near $T_{c}$ inherent in Bose systems, i.e., the Landau-Ginzburg expansion is not possible here. The transition temperature $T_{c}$ shows quite a different interaction dependence between the $n$-fixed and $p$-fixed cases. In the former case $T_{c}$ increases from the ideal gas value $T_{0}$ as $T_{c}/T_{0}= 1+ 2.33 an^{1/3}$, whereas it decreases in the latter as $T_{c}/T_{0}= 1- 3.84a(mp/2\pi\hbar^{2})^{1/5}$. Temperature dependences of basic thermodynamic quantities are clarified explicitly.Comment: 19 pages, 8 figure

BCS and BEC p-wave pairing in Bose-Fermi gases

The pairing of fermionic atoms in a mixture of atomic fermion and boson gases at zero temperature is investigated. The attractive interaction between fermions, that can be induced by density fluctuations of the bosonic background, can give rise to a superfluid phase in the Fermi component of the mixture. The atoms of both species are assumed to be in only one internal state, so that the pairing of fermions is effective only in odd-l channels. No assumption about the value of the ratio between the Fermi velocity and the sound velocity in the Bose gas is made in the derivation of the energy gap equation. The gap equation is solved without any particular "ansatz" for the pairing field or the effective interaction. The p-wave superfluidity is studied in detail. By increasing the strength and/or decreasing the range of the effective interaction a transition of the fermion pairing regime, from the Bardeen-Cooper-Schrieffer state to a system of tightly bound couples can be realized. These composite bosons behave as a weakly-interacting Bose-Einstein condensate.Comment: 14 pages, 6 eps-figures. To be published in European Physical Journal

Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway:A population-based study

BACKGROUND: Comparing the impact of the COVID-19 pandemic on the incidence of newly diagnosed breast tumors and their tumor stage between the Netherlands and Norway will help us understand the effect of differences in governmental and social reactions towards the pandemic.METHODS: Women newly diagnosed with breast cancer in 2017-2021 were selected from the Netherlands Cancer Registry and the Cancer Registry of Norway. The crude breast cancer incidence rate (tumors per 100,000 women) during the first (March-September 2020), second (October 2020-April 2021), and Delta COVID-19 wave (May-December 2021) was compared with the incidence rate in the corresponding periods in 2017, 2018, and 2019. Incidence rates were stratified by age group, method of detection, and clinical tumor stage.RESULTS: During the first wave breast cancer incidence declined to a larger extent in the Netherlands than in Norway (27.7% vs. 17.2% decrease, respectively). In both countries, incidence decreased in women eligible for screening. In the Netherlands, incidence also decreased in women not eligible for screening. During the second wave an increase in the incidence of stage IV tumors in women aged 50-69 years was seen in the Netherlands. During the Delta wave an increase in overall incidence and incidence of stage I tumors was seen in Norway.CONCLUSION: Alterations in breast cancer incidence and tumor stage seem related to a combined effect of the suspension of the screening program, health care avoidance due to the severity of the pandemic, and other unknown factors.</p

How baseline, new-onset, and persistent depressive symptoms are associated with cardiovascular and non-cardiovascular mortality in incident patients on chronic dialysis

AbstractObjectiveDepressive symptoms are associated with mortality among patients on chronic dialysis therapy. It is currently unknown how different courses of depressive symptoms are associated with both cardiovascular and non-cardiovascular mortality.MethodsIn a Dutch prospective nation-wide cohort study among incident patients on chronic dialysis, 1077 patients completed the Mental Health Inventory, both at 3 and 12months after starting dialysis. Cox regression models were used to calculate crude and adjusted hazard ratios (HRs) for mortality for patients with depressive symptoms at 3months only (baseline only), at 12months only (new-onset), and both at 3 and 12months (persistent), using patients without depressive symptoms at 3 and 12months as reference group.ResultsDepressive symptoms at baseline only seemed to be a strong marker for non-cardiovascular mortality (HRadj 1.91, 95% CI 1.26–2.90), whereas cardiovascular mortality was only moderately increased (HRadj 1.41, 95% CI 0.85–2.33). In contrast, new-onset depressive symptoms were moderately associated with both cardiovascular (HRadj 1.66, 95% CI 1.06–2.58) and non-cardiovascular mortality (HRadj 1.46, 95% CI 0.97–2.20). Among patients with persistent depressive symptoms, a poor survival was observed due to both cardiovascular (HRadj 2.14, 95% CI 1.42–3.24) and non-cardiovascular related mortality (HRadj 1.76, 95% CI 1.20–2.59).ConclusionThis study showed that different courses of depressive symptoms were associated with a poor survival after the start of dialysis. In particular, temporary depressive symptoms at the start of dialysis may be a strong marker for non-cardiovascular mortality, whereas persistent depressive symptoms were associated with both cardiovascular and non-cardiovascular mortality

Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma:TRAP Study

PURPOSE: Approximately 15% to 43% of esophageal adenocarcinomas (EACs) are human epidermal growth factor receptor 2 (HER2) positive. Because dual-agent HER2 blockade demonstrated a survival benefit in breast cancer, we conducted a phase II feasibility study of trastuzumab and pertuzumab added to neoadjuvant chemoradiotherapy (nCRT) in patients with EAC. PATIENTS AND METHODS: Patients with resectable HER2-positive EAC received standard nCRT with carboplatin and paclitaxel and 41.4 Gy of radiotherapy, with 4 mg/kg of trastuzumab on day 1, 2 mg/kg per week during weeks 2 to 6, and 6 mg/kg per week during weeks 7, 10, and 13 and 840 mg of pertuzumab every 3 weeks. The primary end point was feasibility, defined as ≥ 80% completion of treatment with both trastuzumab and pertuzumab. An exploratory comparison of survival with a propensity score-matched cohort receiving standard nCRT was performed, as were exploratory pharmacokinetic and biomarker analyses. RESULTS: Of the 40 enrolled patients (78% men; median age, 63 years), 33 (83%) completed treatment with trastuzumab and pertuzumab. No unexpected safety events were observed. R0 resection was achieved in all patients undergoing surgery, with pathologic complete response in 13 patients (34%). Three-year progression-free and overall survival (OS) were 57% and 71%, respectively (median follow-up, 32.1 months). Compared with the propensity score-matched cohort, a significantly longer OS was observed with HER2 blockade (hazard ratio, 0.58; 95% CI, 0.34 to 0.97). Results of pharmacokinetic analysis and activity on [18F]fluorodeoxyglucose positron emission tomography scans did not correlate with survival or pathologic response. Patients with HER2 3+ overexpression or growth factor receptor-bound protein 7 (Grb7) -positive tumors at baseline demonstrated significantly better survival (P = .007) or treatment response (P = .016), respectively. CONCLUSION: Addition of trastuzumab and pertuzumab to nCRT in patients with HER2-positive EAC is feasible and demonstrates potentially promising activity compared with historical controls. HER2 3+ overexpression and Grb7 positivity are potentially predictive for survival and treatment response, respectively

Development, behaviour and sensory processing in Marshall-Smith syndrome and Malan syndrome:phenotype comparison in two related syndromes

Background Ultrarare Marshall-Smith and Malan syndromes, caused by changes of the gene nuclear factor I X (NFIX), are characterised by intellectual disability (ID) and behavioural problems, although questions remain. Here, development and behaviour are studied and compared in a cross-sectional study, and results are presented with genetic findings. Methods Behavioural phenotypes are compared of eight individuals with Marshall-Smith syndrome (three male individuals) and seven with Malan syndrome (four male individuals). Long-term follow-up assessment of cognition and adaptive behaviour was possible in three individuals with Marshall-Smith syndrome. Results Marshall-Smith syndrome individuals have more severe ID, less adaptive behaviour, more impaired speech and less reciprocal interaction compared with individuals with Malan syndrome. Sensory processing difficulties occur in both syndromes. Follow-up measurement of cognition and adaptive behaviour in Marshall-Smith syndrome shows different individual learning curves over time. Conclusions Results show significant between and within syndrome variability. DifferentNFIXvariants underlie distinct clinical phenotypes leading to separate entities. Cognitive, adaptive and sensory impairments are common in both syndromes and increase the risk of challenging behaviour. This study highlights the value of considering behaviour within developmental and environmental context. To improve quality of life, adaptations to environment and treatment are suggested to create a better person-environment fit